For companies engaged in compounding of GLP-1 drug products, the warnings signal a need to reassess labeling, advertising, and promotional strategies
4 AngeliV.TacitoA.PaolicchiA.BarsacchiR.FranziniM.BaldassiniR.et al (2009)
Bellini, C., Mancin, F., Papini, E., & Tavano, R
Name GLP-1 Concentration 5mg per vial Form Lyophilized peptide powder Purity 99%, confirmed by HPLC and MS Packaging Sterile, sealed vial Storage -20C in a dark, dry environment Documentation COA available on request GLP-1 is a receptor agonist peptide developed to mimic the function of glucagon-like peptide-1 , an incretin hormone involved in glucose regulation and appetite signaling
Two independent reviewers performed the study selection process, and any disagreements were resolved by a third reviewer